FDAnews
www.fdanews.com/articles/124230-takeda-profit-falls-on-cost-to-buy-experimental-drugs

Takeda Profit Falls on Cost to Buy Experimental Drugs

February 3, 2010
Takeda Pharmaceutical Co. posted its first profit drop in five quarters on the cost of acquiring experimental drugs to cope with a sales decline for Actos, the world’s biggest-selling diabetes medicine.
Bloomberg